Drug
Ribvd
Ribvd: highest development phase Phase 2, developed by Chugai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| RiBVD NCT01457144 | Phase 2 | Mantle Cell Lymphoma |
Latest
No recent events.
Follow Ribvd on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.